Cargando…
The Future of Regulatory T Cell Therapy: Promises and Challenges of Implementing CAR Technology
Cell therapy with polyclonal regulatory T cells (Tregs) has been translated into the clinic and is currently being tested in transplant recipients and patients suffering from autoimmune diseases. Moreover, building on animal models, it has been widely reported that antigen-specific Tregs are functio...
Autores principales: | Mohseni, Yasmin R., Tung, Sim L., Dudreuilh, Caroline, Lechler, Robert I., Fruhwirth, Gilbert O., Lombardi, Giovanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393941/ https://www.ncbi.nlm.nih.gov/pubmed/32793236 http://dx.doi.org/10.3389/fimmu.2020.01608 |
Ejemplares similares
-
Chimeric antigen receptor‐modified human regulatory T cells that constitutively express IL‐10 maintain their phenotype and are potently suppressive
por: Mohseni, Yasmin R., et al.
Publicado: (2021) -
Spatiotemporal in vivo tracking of polyclonal human regulatory T cells (Tregs) reveals a role for innate immune cells in Treg transplant recruitment
por: Jacob, Jacinta, et al.
Publicado: (2020) -
Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation
por: Safinia, Niloufar, et al.
Publicado: (2015) -
Potential Application of T-Follicular Regulatory Cell Therapy in Transplantation
por: Dudreuilh, Caroline, et al.
Publicado: (2021) -
Radiolabelling of Polyclonally Expanded Human Regulatory T Cells (Treg) with (89)Zr-oxine for Medium-Term In Vivo Cell Tracking
por: Jacob, Jacinta, et al.
Publicado: (2023)